Understand what your liver function testing results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Common causes of high alkaline phosphatase
High alkaline phosphatase most often comes from liver or bile duct disease, then bone conditions like Paget's disease, pregnancy, growth, and some drugs. A GGT test tells liver from bone.
| Cause group | Examples | Typical ALP level | GGT/ALT pattern |
|---|---|---|---|
| Bile duct obstruction | Gallstones, tumors, or strictures | 2-3x higher | GGT high |
| Hepatitis | Viral infections, alcohol, or autoimmune disease | Raised | GGT high; ALT and AST rise with other liver enzymes |
| Paget's disease of bone | Out of range bone remodeling | Over 1,000 U/L | GGT normal; ALT and AST normal |
| Other bone causes | Bone cancers or metastatic tumors; healing fractures | Raised | GGT normal; ALT and AST normal |
| Growth | Pubertal growth spurts in children and teens | 500-800 U/L | GGT normal (bone source) |
| Pregnancy | Third trimester, as the placenta adds enzyme | Raised | Placental source, not liver or bone |
| Medications | Erythromycin, phenytoin, ACE inhibitors | Temporary rise | Varies by drug |
How doctors tell liver from bone
ALT (alanine aminotransferase) and AST (aspartate aminotransferase) help distinguish liver-related ALP elevation from bone sources.
Gamma-glutamyl transferase (GGT) provides additional liver-specific information since it's not found in bone tissue. Bilirubin levels further clarify whether bile duct obstruction contributes to the elevation.
Calcium and phosphorus levels reveal bone metabolism patterns that complement ALP interpretation. Parathyroid hormone (PTH) and vitamin D status influence bone ALP activity and help identify underlying causes of bone-related elevation.
Most healthcare providers confirm elevated ALP by repeating the panel and adding a GGT to distinguish hepatic from non-hepatic sources. If levels remain high, additional tests like ALP isoenzymes can help determine whether the source is liver, bone, or other tissues. This specialized testing separates different forms of the enzyme to help identify the underlying cause.
What alkaline phosphatase actually measures
Alkaline phosphatase (ALP) is an enzyme found primarily in your liver, bones, kidneys, and intestines. Think of it as a cellular worker that helps break down proteins and transport materials across cell membranes. When these tissues become damaged, inflamed, or highly active, they release more ALP into your bloodstream.
Your liver produces the most ALP under normal circumstances, particularly in the bile ducts where it helps process fats. Your bones also generate significant amounts during growth periods or when repairing damage. This dual origin explains why elevated ALP levels may signal either liver problems or bone disorders.
The enzyme gets its name from working best in alkaline (basic) conditions, unlike many other enzymes that prefer acidic environments. This unique characteristic makes it a reliable marker for specific tissue activities that other biomarkers might miss.
What is a normal ALP level?
Standard reference ranges for alkaline phosphatase typically fall between 44-147 U/L for adults, though laboratories may use slightly different ranges. These numbers represent the middle 95% of healthy populations, but "normal" doesn't always mean optimal for your individual health.
Age and sex significantly influence ALP levels. Adults over 65 may show slightly elevated levels as bone turnover increases.
Your optimal range depends on your baseline patterns rather than population averages. Someone whose ALP consistently runs around 60 U/L should investigate if levels suddenly jump to 120 U/L, even though both numbers fall within the reference range. This is why tracking trends matters more than single snapshots.
Low ALP is a separate question with its own causes, covered in the guide to low alkaline phosphatase.
How alkaline phosphatase is tested
Alkaline phosphatase testing requires a simple blood draw from your arm, typically collected in a standard tube without anticoagulants. The sample goes to a laboratory where automated analyzers measure enzyme activity by tracking how quickly ALP breaks down specific substrates.
No special preparation is required, though some laboratories recommend fasting before CMPs that include ALP because intestinal ALP can rise postprandially in certain blood-group secretors, and comprehensive metabolic panels are often drawn fasting. This ensures accurate results for glucose and lipid measurements taken simultaneously. Morning collection provides the most consistent results since enzyme levels can fluctuate slightly throughout the day.
What can change alkaline phosphatase
Alcohol consumption significantly impacts ALP levels, with chronic heavy drinking often associated with persistent elevation through liver damage. Even moderate drinking may temporarily raise levels in sensitive individuals. Weight loss or weight gain may influence ALP through changes in liver metabolism and bone loading patterns.
Exercise intensity affects ALP differently depending on the type. Weight-bearing exercise and resistance training may temporarily raise levels as bones respond to mechanical stress. High-intensity exercise may also be associated with transient liver enzyme elevation, including ALP, particularly in untrained individuals.
Sleep quality and stress levels may indirectly influence ALP through their effects on liver function and bone metabolism. Chronic stress elevates cortisol, which can accelerate bone resorption over formation. Adequate sleep supports normal enzyme regulation and cellular repair processes.
Test 100+ biomarkers
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers
One blood draw. A full picture of your health, explained in plain language.
Why testing alkaline phosphatase is worth it
ALP can flag liver and bone problems before symptoms appear, since liver disease can progress silently. Tracked over time, it shows whether treatment is working and can reveal medication side effects early. Superpower's blood panels measure ALP alongside liver and metabolic markers, so you and your care team can tell liver-related elevation from bone-related causes.
Frequently Asked Questions
References
- Kwo PY, Cohen SM, Lim JK (2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. *The American journal of gastroenterology*, *112*(1), 18-35. https://doi.org/10.1038/ajg.2016.517
- Ralston SH, Corral-Gudino L, Cooper C, Francis RM, Fraser WD, Gennari L, Guañabens N, Javaid MK, Layfield R, O'Neill TW, Russell RGG, Stone MD, Simpson K, Wilkinson D, Wills R, Zillikens MC, Tuck SP (2019). Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline. *Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research*, *34*(4), 579-604. https://doi.org/10.1002/jbmr.3657
- Ferianec V, Linhartová L (2011). Extreme elevation of placental alkaline phosphatase as a marker of preterm delivery, placental insufficiency and low birth weight. *Neuro endocrinology letters*, *32*(2), 154-7. https://pubmed.ncbi.nlm.nih.gov/21552196/
- Lowe D, Sanvictores T, Zubair M, John S (2026). *Serum alkaline phosphatase: Clinical and laboratory perspectives*. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459201/
- Minisola S, Cipriani C, Colangelo L, Labbadia G, Pepe J, Magnusson P (2025). Diagnostic Approach to Abnormal Alkaline Phosphatase Value. *Mayo Clinic proceedings*, *100*(4), 712-728. https://doi.org/10.1016/j.mayocp.2024.11.019
- Sen AT, Derman O, Kinik E (2000). The relationship between osteocalcin levels and sexual stages of puberty in male children. *The Turkish journal of pediatrics*, *42*(4), 281-5. https://pubmed.ncbi.nlm.nih.gov/11196743/
- Ozarda Y (2016). Reference intervals: current status, recent developments and future considerations. *Biochemia medica*, *26*(1), 5-16. https://doi.org/10.11613/BM.2016.001
- Cejka D, Wakolbinger-Habel R, Zitt E, Fahrleitner-Pammer A, Amrein K, Dimai HP, Muschitz C (2023). [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)]. *Wiener medizinische Wochenschrift (1946)*, *173*(13-14), 299-318. https://doi.org/10.1007/s10354-022-00989-0
- Greenblatt MB, Tsai JN, Wein MN (2017). Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. *Clinical chemistry*, *63*(2), 464-474. https://doi.org/10.1373/clinchem.2016.259085
- Uemura H, Uemura H, Matsubara N, Kinuya S, Hosono M, Yajima Y, Doi T (2017). Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases. *International journal of clinical oncology*, *22*(5), 954-963. https://doi.org/10.1007/s10147-017-1130-1
- Sharanek A, Burban A, Ciriaci N, Guillouzo A (2019). Pro-inflammatory cytokines enhance dilatation of bile canaliculi caused by cholestatic antibiotics. *Toxicology in vitro : an international journal published in association with BIBRA*, *58*, 51-59. https://doi.org/10.1016/j.tiv.2019.03.015
- *Barbiturates* (2021). In *LiverTox: Clinical and Research Information on Drug-Induced Liver Injury*. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/NBK548260/
- *Angiotensin-converting enzyme inhibitors* (2018). In *LiverTox: Clinical and Research Information on Drug-Induced Liver Injury*. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/NBK548912/
- Dahir KM, Nunes ME (2007). *Hypophosphatasia*. In *GeneReviews*. University of Washington, Seattle. https://www.ncbi.nlm.nih.gov/books/NBK1150/
- Wu JF, Jha P, Doucette S, Abid H (2022). Significantly Elevated Alkaline Phosphatase Caused by Congestive Hepatopathy in the Setting of Heart Failure with Preserved Ejection Fraction. *WMJ : official publication of the State Medical Society of Wisconsin*, *121*(1), E14-E17. https://pubmed.ncbi.nlm.nih.gov/35442588/
- Matsushita M, Harajiri S, Tabata S, Yukimasa N, Muramoto Y, Komoda T (2013). [Alkaline phosphatase activity in blood group B or O secretors is fluctuated by the dinner intake of previous night]. *Rinsho byori. The Japanese journal of clinical pathology*, *61*(4), 307-12. https://pubmed.ncbi.nlm.nih.gov/23855186/
- Ciecko C, Okut H, Lancaster B, Schwasinger-Schmidt T (2023). Prevalence of elevated alkaline phosphatase levels among post-bariatric surgery patients. *Langenbeck's archives of surgery*, *408*(1), 285. https://doi.org/10.1007/s00423-023-03021-0
- Honda A, Kon M, Matsubayashi T, Suzuki Y (2020). Short-Term Intermittent Hypoxic Resistance Training Does Not Impair Osteogenic Response in Sea Level Residents. *High altitude medicine & biology*, *21*(2), 160-166. https://doi.org/10.1089/ham.2019.0089
- Niemelä M, Kangastupa P, Niemelä O, Bloigu R, Juvonen T (2016). Individual responses in biomarkers of health after marathon and half-marathon running: is age a factor in troponin changes?. *Scandinavian journal of clinical and laboratory investigation*, *76*(7), 575-580. https://doi.org/10.1080/00365513.2016.1225122
- Ng JS, Chin KY (2021). Potential mechanisms linking psychological stress to bone health. *International journal of medical sciences*, *18*(3), 604-614. https://doi.org/10.7150/ijms.50680
- Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M (2019). Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. *Hepatology (Baltimore, Md.)*, *69*(1), 394-419. https://doi.org/10.1002/hep.30145
- Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005). Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. *The New England journal of medicine*, *353*(9), 898-908. https://doi.org/10.1056/NEJMoa044241
- Siramolpiwat S, Sakonlaya D (2017). Clinical and histologic features of Azathioprine-induced hepatotoxicity. *Scandinavian journal of gastroenterology*, *52*(8), 876-880. https://doi.org/10.1080/00365521.2017.1311936
- *Estrogens and oral contraceptives* (2020). In *LiverTox: Clinical and Research Information on Drug-Induced Liver Injury*. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/NBK548539/
Heart & Vascular Health
Metabolic Health
Energy
Liver Health
Kidney
Sex Hormones
Thyroid Health
Nutrients
Immune System
Inflammation